BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 20968137)

  • 1. Outcomes of radiation therapy for T1 glottic carcinoma from an Italian regional series with doses ranging from 60 to 66 Gy.
    Manzo R; Ravo V; Murino P; Morra A; Panetti G; Laudati A; Prisco A; Panelli G; Muto P
    Tumori; 2010; 96(4):577-81. PubMed ID: 20968137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stage I (T1 N0 M0) squamous cell carcinoma of the laryngeal glottis: therapeutic results and voice preservation.
    Spector JG; Sessions DG; Chao KS; Haughey BH; Hanson JM; Simpson JR; Perez CA
    Head Neck; 1999 Dec; 21(8):707-17. PubMed ID: 10562683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radical radiotherapy for early glottic cancer: Results in a series of 1087 patients from two Italian radiation oncology centers. I. The case of T1N0 disease.
    Cellai E; Frata P; Magrini SM; Paiar F; Barca R; Fondelli S; Polli C; Livi L; Bonetti B; Vitali E; De Stefani A; Buglione M; Biti G
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1378-86. PubMed ID: 16095847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiation therapy in early glottic carcinoma: uni- and multivariate analysis of prognostic factors affecting local control.
    Sakata K; Aoki Y; Karasawa K; Hasezawa K; Muta N; Nakagawa K; Terahara A; Onogi Y; Sasaki Y; Akanuma A
    Int J Radiat Oncol Biol Phys; 1994 Dec; 30(5):1059-64. PubMed ID: 7961012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperfractionated radiotherapy for T2N0 glottic carcinoma: a retrospective analysis at 10 years follow-up in a series of 60 consecutive patients.
    Bignardi M; Antognoni P; Sanguineti G; Magli A; Molteni M; Merlotti A; Richetti A; Tordiglione M; Conte L; Magno L
    Tumori; 2004; 90(3):317-23. PubMed ID: 15315312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of failure for early-stage glottic carcinoma: 10 years' experience in conformal radiotherapy era.
    Sert F; Kaya I; Ozturk K; Esassolak M
    J Cancer Res Ther; 2019; 15(3):576-581. PubMed ID: 31169223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of fraction size, total dose, and overall time on local control of T1-T2 glottic carcinoma.
    Le QT; Fu KK; Kroll S; Ryu JK; Quivey JM; Meyler TS; Krieg RM; Phillips TL
    Int J Radiat Oncol Biol Phys; 1997 Aug; 39(1):115-26. PubMed ID: 9300746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of radiation fraction size on local control rates for early glottic carcinoma. A model analysis for in vivo tumor growth and radio-response parameters.
    Ricciardelli EJ; Weymuller EA; Koh WJ; Austin-Seymour M; DeSautel MG; Laramore GE
    Arch Otolaryngol Head Neck Surg; 1994 Jul; 120(7):737-42. PubMed ID: 8018326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of radiotherapy for T2N0 glottic carcinoma: does the "2" stand for twice-daily treatment?
    Garden AS; Forster K; Wong PF; Morrison WH; Schechter NR; Ang KK
    Int J Radiat Oncol Biol Phys; 2003 Feb; 55(2):322-8. PubMed ID: 12527044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term results of radiotherapy for T1a and T1bN0M0 glottic carcinoma.
    Nomiya T; Nemoto K; Wada H; Takai Y; Yamada S
    Laryngoscope; 2008 Aug; 118(8):1417-21. PubMed ID: 18528306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radical radiotherapy for early glottic cancer: Results in a series of 1087 patients from two Italian radiation oncology centers. II. The case of T2N0 disease.
    Frata P; Cellai E; Magrini SM; Bonetti B; Vitali E; Tonoli S; Buglione M; Paiar F; Barca R; Fondelli S; Polli C; Livi L; Biti G
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1387-94. PubMed ID: 16115737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased local control following radiation therapy alone in early-stage glottic carcinoma with anterior commissure extension.
    Zouhair A; Azria D; Coucke P; Matzinger O; Bron L; Moeckli R; Do HP; Mirimanoff RO; Ozsahin M
    Strahlenther Onkol; 2004 Feb; 180(2):84-90. PubMed ID: 14762660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of treatment time and smoking on local control and complications in T1 glottic cancer.
    van der Voet JC; Keus RB; Hart AA; Hilgers FJ; Bartelink H
    Int J Radiat Oncol Biol Phys; 1998 Sep; 42(2):247-55. PubMed ID: 9788401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conservative treatment of early glottic carcinomas with exclusive radiotherapy.
    Thariat J; Bruchon Y; Bonnetain F; Barillot I; Truc G; Peignaux K; Horiot JC; Maingon P
    Cancer Radiother; 2004 Oct; 8(5):288-96. PubMed ID: 15561594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of external radiotherapy, laser microsurgery and partial laryngectomy for the treatment of T1N0M0 glottic carcinomas: a retrospective evaluation.
    Rosier JF; Grégoire V; Counoy H; Octave-Prignot M; Rombaut P; Scalliet P; Vanderlinden F; Hamoir M
    Radiother Oncol; 1998 Aug; 48(2):175-83. PubMed ID: 9783889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypofractionated radiotherapy for T1N0M0 glottic cancer: retrospective analysis of two different cohorts of dose-fractionation schedules from a single institution.
    Laskar SG; Baijal G; Murthy V; Chilukuri S; Budrukkar A; Gupta T; Agarwal JP
    Clin Oncol (R Coll Radiol); 2012 Dec; 24(10):e180-6. PubMed ID: 22862908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiotherapy for T1 carcinoma of the glottis.
    Tombolini V; Zurlo A; Cavaceppi P; Sarro A; Guidi C; Osti MF; Vitturini A; Banelli E
    Tumori; 1995; 81(6):414-8. PubMed ID: 8804466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Primary radiotherapy of laryngeal carcinoma. An analysis of the therapeutic results and of the the relapse behavior in 283 patients].
    Rübe C; Micke O; Grevers G; Rohloff R; Kaufmann H; Busch M; Willich N
    Strahlenther Onkol; 1997 Feb; 173(2):83-90. PubMed ID: 9072844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of stage IV glottic carcinoma: therapeutic outcomes.
    Spector GJ; Sessions DG; Lenox J; Newland D; Simpson J; Haughey BH
    Laryngoscope; 2004 Aug; 114(8):1438-46. PubMed ID: 15280724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of stage II (T2N0M0) glottic carcinoma by radiotherapy and conservation surgery.
    Spector JG; Sessions DG; Chao KS; Hanson JM; Simpson JR; Perez CA
    Head Neck; 1999 Mar; 21(2):116-23. PubMed ID: 10091979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.